Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation. [electronic resource]
Producer: 20170721Description: 67-73 p. digitalISSN:- 1532-2777
- Adipose Tissue -- metabolism
- Animals
- Colchicine -- pharmacology
- Diabetes Mellitus, Type 2 -- complications
- Gout Suppressants -- pharmacology
- Humans
- Immunity, Innate
- Inflammasomes -- metabolism
- Inflammation
- Insulin Resistance
- Macrophages -- metabolism
- Metabolic Diseases -- complications
- Mice
- NLR Family, Pyrin Domain-Containing 3 Protein -- metabolism
- Obesity -- complications
- Risk Factors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.